Cargando…

FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness

OBJECTIVE: To investigate the usefulness of Fibroblast Growth Factor 23 (FGF-23) and vitamin D as possible biomarkers of pre-clinical atherosclerosis, assessed as arterial stiffness (AS), in a group of subjects with type 1 diabetes (T1DM) and no previous cardiovascular events. RESEARCH DESIGN AND ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Llauradó, Gemma, Megia, Ana, Cano, Albert, Giménez-Palop, Olga, Simón, Inmaculada, González-Sastre, Montserrat, Berlanga, Eugenio, Fernández-Veledo, Sonia, Vendrell, Joan, González-Clemente, José-Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604080/
https://www.ncbi.nlm.nih.gov/pubmed/26462160
http://dx.doi.org/10.1371/journal.pone.0140222
_version_ 1782394999202119680
author Llauradó, Gemma
Megia, Ana
Cano, Albert
Giménez-Palop, Olga
Simón, Inmaculada
González-Sastre, Montserrat
Berlanga, Eugenio
Fernández-Veledo, Sonia
Vendrell, Joan
González-Clemente, José-Miguel
author_facet Llauradó, Gemma
Megia, Ana
Cano, Albert
Giménez-Palop, Olga
Simón, Inmaculada
González-Sastre, Montserrat
Berlanga, Eugenio
Fernández-Veledo, Sonia
Vendrell, Joan
González-Clemente, José-Miguel
author_sort Llauradó, Gemma
collection PubMed
description OBJECTIVE: To investigate the usefulness of Fibroblast Growth Factor 23 (FGF-23) and vitamin D as possible biomarkers of pre-clinical atherosclerosis, assessed as arterial stiffness (AS), in a group of subjects with type 1 diabetes (T1DM) and no previous cardiovascular events. RESEARCH DESIGN AND METHODS: 68 T1DM patients and 68 age- and sex-matched controls were evaluated for 1) age, sex, diabetes duration, physical activity, smoking, alcohol intake, BMI, blood pressure, fasting plasma glucose, HbA(1c), estimated glomerular filtration rate (eGFR) and lipid profile; 2) microvascular complications; 3) blood concentrations of FGF-23 and mineral metabolism parameters (calcium, phosphate, parathyroid hormone (PTH) and 25-hydroxy-vitamin D (25(OH)D)); 4) AS, assessed as aortic pulse wave velocity (aPWV); and 5) low-grade inflammation (hsCRP, IL-6, sTNFαR1, sTNFαR2) and endothelial dysfunction (ED) markers (ICAM-1, VCAM-1, E-Selectin). RESULTS: Patients with T1DM had higher aPWV compared with controls (p<0.001), but they did not present differences in 25(OH)D (70.3(50.4–86.2)nmol/L vs. 70.7(59.7–83.0)nmol/L; p = 0.462) and in FGF-23 plasma concentrations (70.1(38.4–151.9)RU/mL vs. 77.6(51.8–113.9)RU/mL; p = 0.329). In T1DM patients, higher concentrations of FGF-23 were positively associated with aPWV after adjusting for eGFR and classical cardiovascular risk factors (model 1: ß = 0.202, p = 0.026), other mineral metabolism parameters (model 2: ß = 0.214, p = 0.015), microvascular complications, low-grade inflammation and ED markers (model 3: ß = 0.170, p = 0.045). Lower 25(OH)D concentrations were also associated with higher aPWV after adjusting for all the above-mentioned factors (model 3: ß = -0.241, p = 0.015). CONCLUSIONS: We conclude that both FGF-23 plasma concentrations (positively) and 25(OH)D serum concentrations (negatively) are associated with AS in patients with T1DM and no previous cardiovascular events.
format Online
Article
Text
id pubmed-4604080
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46040802015-10-20 FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness Llauradó, Gemma Megia, Ana Cano, Albert Giménez-Palop, Olga Simón, Inmaculada González-Sastre, Montserrat Berlanga, Eugenio Fernández-Veledo, Sonia Vendrell, Joan González-Clemente, José-Miguel PLoS One Research Article OBJECTIVE: To investigate the usefulness of Fibroblast Growth Factor 23 (FGF-23) and vitamin D as possible biomarkers of pre-clinical atherosclerosis, assessed as arterial stiffness (AS), in a group of subjects with type 1 diabetes (T1DM) and no previous cardiovascular events. RESEARCH DESIGN AND METHODS: 68 T1DM patients and 68 age- and sex-matched controls were evaluated for 1) age, sex, diabetes duration, physical activity, smoking, alcohol intake, BMI, blood pressure, fasting plasma glucose, HbA(1c), estimated glomerular filtration rate (eGFR) and lipid profile; 2) microvascular complications; 3) blood concentrations of FGF-23 and mineral metabolism parameters (calcium, phosphate, parathyroid hormone (PTH) and 25-hydroxy-vitamin D (25(OH)D)); 4) AS, assessed as aortic pulse wave velocity (aPWV); and 5) low-grade inflammation (hsCRP, IL-6, sTNFαR1, sTNFαR2) and endothelial dysfunction (ED) markers (ICAM-1, VCAM-1, E-Selectin). RESULTS: Patients with T1DM had higher aPWV compared with controls (p<0.001), but they did not present differences in 25(OH)D (70.3(50.4–86.2)nmol/L vs. 70.7(59.7–83.0)nmol/L; p = 0.462) and in FGF-23 plasma concentrations (70.1(38.4–151.9)RU/mL vs. 77.6(51.8–113.9)RU/mL; p = 0.329). In T1DM patients, higher concentrations of FGF-23 were positively associated with aPWV after adjusting for eGFR and classical cardiovascular risk factors (model 1: ß = 0.202, p = 0.026), other mineral metabolism parameters (model 2: ß = 0.214, p = 0.015), microvascular complications, low-grade inflammation and ED markers (model 3: ß = 0.170, p = 0.045). Lower 25(OH)D concentrations were also associated with higher aPWV after adjusting for all the above-mentioned factors (model 3: ß = -0.241, p = 0.015). CONCLUSIONS: We conclude that both FGF-23 plasma concentrations (positively) and 25(OH)D serum concentrations (negatively) are associated with AS in patients with T1DM and no previous cardiovascular events. Public Library of Science 2015-10-13 /pmc/articles/PMC4604080/ /pubmed/26462160 http://dx.doi.org/10.1371/journal.pone.0140222 Text en © 2015 Llauradó et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Llauradó, Gemma
Megia, Ana
Cano, Albert
Giménez-Palop, Olga
Simón, Inmaculada
González-Sastre, Montserrat
Berlanga, Eugenio
Fernández-Veledo, Sonia
Vendrell, Joan
González-Clemente, José-Miguel
FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness
title FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness
title_full FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness
title_fullStr FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness
title_full_unstemmed FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness
title_short FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness
title_sort fgf-23/vitamin d axis in type 1 diabetes: the potential role of mineral metabolism in arterial stiffness
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604080/
https://www.ncbi.nlm.nih.gov/pubmed/26462160
http://dx.doi.org/10.1371/journal.pone.0140222
work_keys_str_mv AT llauradogemma fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness
AT megiaana fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness
AT canoalbert fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness
AT gimenezpalopolga fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness
AT simoninmaculada fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness
AT gonzalezsastremontserrat fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness
AT berlangaeugenio fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness
AT fernandezveledosonia fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness
AT vendrelljoan fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness
AT gonzalezclementejosemiguel fgf23vitamindaxisintype1diabetesthepotentialroleofmineralmetabolisminarterialstiffness